AI
Saturday, November 30, 2024 8:44:42 PM
Take some time to get a billion? Can you be more specific?
I have to skip the elementary level of calculation about the revenue.
Do you think those BPs facing patent cliff will have the patience to wait for some time?
See this collaboration trial between Merck and Daiichi Sankyo about the combination of keytruda with CSF1R inhibitor which was terminated early for insufficient evidence of clinical efficacy. Can you imagine what could happen if this two is combined with DCVax-L? Sort out how many types of cancers have immunosuppression dominated by tumor-associated macrophages first and then redo your calculation.
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors
https://clinicaltrials.gov/study/NCT02452424
I have to skip the elementary level of calculation about the revenue.
Do you think those BPs facing patent cliff will have the patience to wait for some time?
See this collaboration trial between Merck and Daiichi Sankyo about the combination of keytruda with CSF1R inhibitor which was terminated early for insufficient evidence of clinical efficacy. Can you imagine what could happen if this two is combined with DCVax-L? Sort out how many types of cancers have immunosuppression dominated by tumor-associated macrophages first and then redo your calculation.
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors
https://clinicaltrials.gov/study/NCT02452424
